RedHill Biopharma reported $-4.41M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.





Equity Capital And Reserves Change Date
Cara Therapeutics USD 27.87M 5.06M Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
Cronos Group USD 1.09B 11.39M Dec/2025
RedHill Biopharma USD -4.41M 271K Jun/2025